Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Short term Debt (2022 - 2025)

Celularity has reported Short term Debt over the past 4 years, most recently at $4.3 million for Q3 2025.

  • Quarterly results put Short term Debt at $4.3 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $4.3 million (changed N/A YoY), and the annual figure for FY2024 was $2.5 million, down 87.52%.
  • Short term Debt for Q3 2025 was $4.3 million at Celularity, roughly flat from $4.3 million in the prior quarter.
  • Over the last five years, Short term Debt for CELU hit a ceiling of $39.3 million in Q3 2022 and a floor of $2.5 million in Q4 2024.
  • Median Short term Debt over the past 4 years was $15.4 million (2023), compared with a mean of $17.4 million.
  • Biggest five-year swings in Short term Debt: tumbled 47.05% in 2023 and later tumbled 87.52% in 2024.
  • Celularity's Short term Debt stood at $37.6 million in 2022, then tumbled by 47.05% to $19.9 million in 2023, then tumbled by 87.52% to $2.5 million in 2024, then skyrocketed by 72.39% to $4.3 million in 2025.
  • The last three reported values for Short term Debt were $4.3 million (Q3 2025), $4.3 million (Q2 2025), and $4.2 million (Q1 2025) per Business Quant data.